Impacto Públicocivic observatory
Portuguêspt-PTEnglishcurrent languageEspañoles-ES

PUBLIC CONTRACT · 2022

Medicamentos do grupo 4: sangue

Contract value
€352,535.95
Signed on
22 December 2022
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9904510

PUBLISHED SUBJECT

41/282/2023 - Medicamentos do grupo 4: sangue

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
NOVARTIS FARMA-PROD.FARMACÊUTICOS,SA. · Tax ID 500063524
Awardee
Generis Farmacêutica, SA · Tax ID 508107997
Awardee
LAB. PFIZER, LDA. · Tax ID 500162166
Awardee
ASTRAZENECA - PROD.FARMACEUTICOS, LDA. · Tax ID 502942240
Awardee
BOERINGER INGLHEIM PORTUGAL · Tax ID 500293023
Awardee
VIFOR PHARMA PORTUGAL, SA · Tax ID 516677586
Awardee
Bayer Portugal LDA · Tax ID 500043256

Values and timeline

Contract price
€352,535.95
Procedure base price
€0.00
Total effective price
Not reported on Portal BASE
Publication date
3 April 2023
Award date
22 December 2022
Signing date
22 December 2022
Performance period
366 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement
CP 2020/18 - Medicamentos do grupo 4: sangue
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
6191382

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts